logo
Select company
Select metric
$ -2.56MNet Cash Flow - Investing
VS
Market
63
Sector
37
Industry
25
History
48
$ 18.81Close
$ 7.38 - $ 61.57 52-Week Range
Ticker Information

Ticker

TNXP

Company Name

TONIX PHARMACEUTICALS HOLDING CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TONIX PHARMACEUTICALS HOLDING CORP - Net Cash Flow - Investing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TNXP - CF - Investing Historical data
DateNet Cash Flow - Investing
6/30/2025$ -2.56M
3/31/2025$ -18K
12/31/2024$ -120K
9/30/2024$ -548K
6/30/2024$ -1.36M
3/31/2024$ -25.38M
12/31/2023$ -29.07M
9/30/2023$ -33.31M
6/30/2023$ -41.31M
3/31/2023$ -31.73M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TONIX PHARMACEUTICALS HOLDING CORP's latest trailing twelve months (TTM) CF - Investing stands at $ -4.04M.
  • Over the past 5 years, TONIX PHARMACEUTICALS HOLDING CORP's average CF - Investing has been $ -24.37M.
  • The median CF - Investing for TONIX PHARMACEUTICALS HOLDING CORP during this period was $ -19.8M
  • TONIX PHARMACEUTICALS HOLDING CORP reached its highest CF - Investing over the past 5 years at $ -18K.
  • The lowest CF - Investing recorded by TONIX PHARMACEUTICALS HOLDING CORP in the same timeframe $ -69.1M

TONIX PHARMACEUTICALS HOLDING CORP's CF - Investing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Investing Benchmarks
CompanyCF - Investing
PRTA : PROTHENA CORP PUBLIC LTD CO $ -180KCAPR : CAPRICOR THERAPEUTICS INC $ -82.94MLCTX : LINEAGE CELL THERAPEUTICS INC $ 8.41MRLAY : RELAY THERAPEUTICS INC $ 20.45MABSI : ABSCI CORP $ 27.84MPRME : PRIME MEDICINE INC $ 53.62MTVRD : TVARDI THERAPEUTICS INC $ -12.93MOCGN : OCUGEN INC $ -710KFATE : FATE THERAPEUTICS INC $ 110.54MSRZN : SURROZEN INC $ -64K

Definition of Net Cash Flow - Investing

[Cash Flow Statement] The amount of cash inflow (outflow) from investing activities. Investing actives include disposal (expenditure) of capital assets [CapEx], sale (purchase) of business [NCFBus] and of investments [NCFInv].

TNXP - Net Cash Flow - Investing, Last 5 years

$ -69.1M

Minimum

Sep 30, 2022

$ -18K

Maximum

Mar 31, 2025

$ -24.37M

Average

$ -19.8M

Median

CF - Investing Benchmark Analysis

The chart above depicts the distribution of CF - Investing for companies in the Total Stock Market. The average CF - Investing of the companies is $ -35.26M with a standard deviation of $ 83.34M.
The following table provides additional summary stats:
CF - Investing in the Market:
filtered constituents3.17K
min$ -292.23M
max$ 241M
average$ -35.26M
median$ -6.38M
std$ 83.34M